Attached files
| file | filename |
|---|---|
| EX-10.16 - EX-10.16 - Edwards Lifesciences Corp | ex-101610xkq42020.htm |
| 10-K - 10-K - Edwards Lifesciences Corp | ew-20201231.htm |
| EX-10.18 - EX-10.18 - Edwards Lifesciences Corp | ex-101810xkq42020.htm |
| EX-31.2 - EX-31.2 - Edwards Lifesciences Corp | ex-31210xkq42020.htm |
| EX-21.1 - EX-21.1 - Edwards Lifesciences Corp | ex-21110xkq42020.htm |
| EX-10.17 - EX-10.17 - Edwards Lifesciences Corp | ex-101710xkq42020.htm |
| EX-32 - EX-32 - Edwards Lifesciences Corp | ex-3210xkq42020.htm |
| EX-4.2 - EX-4.2 - Edwards Lifesciences Corp | ex-4210xkq42020.htm |
| EX-31.1 - EX-31.1 - Edwards Lifesciences Corp | ex-31110xkq42020.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-33054, 333-33056, 333-40434, 333-52334, 333-52346, 333-60670, 333-98219, 333-105961, 333-127260, 333-150810, 333-154242, 333-168462, 333-183106, 333-192229, 333-195853, 333-204180, 333-211333, and 333-217909) and Form S-3 (No. 333-232866) of Edwards Lifesciences Corporation of our report dated February 12, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Irvine, California
February 12, 2021